Total Payments
$13,024
2024 Payments
$1,091
Companies
70
Transactions
796
Medicare Patients
10,996
Medicare Billing
$789,383
Payment Breakdown by Category
Food & Beverage$12,973 (99.6%)
Education$50.60 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,973 | 789 | 99.6% |
| Education | $50.60 | 7 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,252 | 144 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,782 | 108 | $0 (2024) |
| Lilly USA, LLC | $1,139 | 77 | $0 (2024) |
| Amgen Inc. | $655.54 | 42 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $596.50 | 42 | $0 (2022) |
| GlaxoSmithKline, LLC. | $580.04 | 35 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $526.33 | 29 | $0 (2024) |
| ABBVIE INC. | $523.90 | 29 | $0 (2024) |
| PFIZER INC. | $494.36 | 33 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $460.00 | 25 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,091 | 58 | Novo Nordisk Inc ($399.06) |
| 2023 | $1,163 | 67 | Novo Nordisk Inc ($256.60) |
| 2022 | $1,466 | 83 | Novo Nordisk Inc ($281.55) |
| 2021 | $1,678 | 105 | Lilly USA, LLC ($252.38) |
| 2020 | $1,304 | 75 | AstraZeneca Pharmaceuticals LP ($287.10) |
| 2019 | $1,789 | 110 | Novo Nordisk Inc ($254.07) |
| 2018 | $2,266 | 144 | Novo Nordisk Inc ($326.68) |
| 2017 | $2,269 | 154 | Novo Nordisk Inc ($290.69) |
All Payment Transactions
796 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Respiratory | ||||||
| 11/11/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Obesity | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.94 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.52 | General |
| 09/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.27 | General |
| 09/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: DIABETES | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Respiratory | ||||||
| 08/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Inflammation | ||||||
| 08/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: RESPIRATORY | ||||||
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,547 | 3,327 | $343,025 | $191,933 |
| 2022 | 18 | 2,535 | 3,306 | $337,255 | $189,616 |
| 2021 | 19 | 2,924 | 3,880 | $382,570 | $222,826 |
| 2020 | 26 | 2,990 | 3,797 | $356,050 | $185,008 |
Total Patients
10,996
Total Services
14,310
Medicare Billing
$789,383
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 327 | 638 | $102,220 | $57,744 | 56.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 350 | 350 | $64,840 | $44,006 | 67.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 347 | 355 | $70,905 | $40,279 | 56.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 155 | 194 | $24,250 | $11,588 | 47.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 337 | 337 | $16,985 | $5,949 | 35.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 32 | 37 | $11,100 | $5,797 | 52.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 40 | 40 | $9,400 | $5,787 | 61.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 23 | 26 | $7,800 | $5,576 | 71.5% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 137 | 261 | $6,525 | $4,123 | 63.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 317 | 428 | $6,430 | $3,595 | 55.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $3,575 | $2,104 | 58.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 39 | 47 | $3,525 | $1,777 | 50.4% |
| 81002 | Urinalysis, manual test | Office | 2023 | 309 | 388 | $5,820 | $1,320 | 22.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 18 | 32 | $2,400 | $991.38 | 41.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 88 | $3,080 | $784.80 | 25.5% |
| 83026 | Hemoglobin level | Office | 2023 | 59 | 70 | $2,100 | $275.10 | 13.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 22 | 23 | $2,070 | $236.88 | 11.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 259 | 487 | $77,995 | $45,620 | 58.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 333 | 333 | $61,790 | $42,745 | 69.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 327 | 332 | $66,500 | $40,274 | 60.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 247 | 350 | $43,750 | $21,742 | 49.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 50 | 58 | $17,400 | $9,172 | 52.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 47 | 47 | $11,045 | $6,252 | 56.6% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 327 | 327 | $16,350 | $5,840 | 35.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 112 | 231 | $5,775 | $3,567 | 61.8% |
About Dr. Barbara Schwartz, MD
Dr. Barbara Schwartz, MD is a Internal Medicine healthcare provider based in Winter Park, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437101953.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Schwartz, MD has received a total of $13,024 in payments from pharmaceutical and medical device companies, with $1,091 received in 2024. These payments were reported across 796 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($12,973).
As a Medicare-enrolled provider, Schwartz has provided services to 10,996 Medicare beneficiaries, totaling 14,310 services with total Medicare billing of $789,383. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Winter Park, FL
- Active Since 05/16/2006
- Last Updated 01/13/2011
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437101953
Products in Payments
- FARXIGA (Drug) $1,338
- Ozempic (Drug) $1,201
- JARDIANCE (Drug) $537.03
- TRULICITY (Drug) $424.59
- XARELTO (Drug) $373.25
- Rybelsus (Drug) $356.14
- ENTRESTO (Drug) $317.77
- SHINGRIX (Biological) $290.64
- Victoza (Drug) $278.70
- JANUVIA (Drug) $259.48
- INVOKANA (Drug) $211.29
- UBRELVY (Drug) $201.83
- Kerendia (Drug) $200.88
- MOUNJARO (Drug) $200.31
- TOUJEO (Drug) $194.88
- Otezla (Drug) $170.99
- Prolia (Biological) $170.48
- TRELEGY ELLIPTA (Drug) $165.42
- Edarbyclor (Drug) $156.25
- SOLIQUA (Drug) $150.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Winter Park
Dr. Ashish Gupta, M.d, M.D
Internal Medicine — Payments: $325,360
Internal Medicine $325,360
Sayed Hussain, M.d, M.D
Internal Medicine — Payments: $60,097
Internal Medicine $60,097
Dr. Daniel Wubneh, D.o, D.O
Internal Medicine — Payments: $17,258
Internal Medicine $17,258
Dr. Sergio Menendez-Aponte, Md, MD
Internal Medicine — Payments: $17,169
Internal Medicine $17,169
Raghav Sharma, Md, MD
Internal Medicine — Payments: $9,229
Internal Medicine $9,229
Rajnish Puri, D.o, D.O
Internal Medicine — Payments: $8,992
Internal Medicine $8,992